About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc. engages in the development, manufacturing, marketing, sales and distribution of well-recognized, brand name, over-the-counter (OTC) health and personal care products to mass merchandisers, drug, food, dollar, convenience, club and e-commerce stores in North America (the United States and Canada) and in Australia and certain other international markets. The company has grown its product portfolio both organically and through acquisitions. The company develops its existing brands by investing in new product lines, brand extensions and strong advertising support. Acquisitions of consumer health and personal care brands have also been an important part of the company’s growth strategy. The company pursues this growth following an acquisition through spending on advertising and marketing support, new sales and marketing strategies, improved packaging and formulations and innovative development of brand extensions. The company’s products are sold through multiple channels, including mass merchandisers, drug, food, dollar, convenience, club and e-commerce stores, which reduces its exposure to any single distribution channel. During 2023, approximately 58.1% of the company’s total revenues were from major brands. In 2023, these brands included BC and Goody's, Chloraseptic, Compound W, Debrox, Dramamine, Fess, Fleet, Hydralyte, Monistat, Nix, and Summer's Eve. Segments The company operates through two reportable segments: North American OTC Healthcare and International OTC Healthcare. North American OTC Healthcare BC/Goody's: The BC and Goody's brands feature over-the-counter, fast-acting pain relief powder. Boudreaux's Butt Paste: Products include various diaper rash treatments and skin protectants manufactured with high-quality ingredients. Chloraseptic: Products include sprays and lozenges to relieve sore throats and mouth pain. Clear Eyes: Effective line of eye care products that provide soothing comfort, including relief from redness and itchiness. Compound W: Provides safe and effective at-home removal of common and plantar warts. Debrox: Provides a safe and gentle way to remove excess ear wax or water from ear canal. DenTek: Products include dental guards, floss picks, interdental brushes, dental repair and kits, and tongue cleaners. Dramamine: Includes non-drowsy, kids', original and nausea-free formulas. Fleet: Products include enemas and other laxative products. Gaviscon: Creates a protective foam barrier to help block stomach acid from splashing up into the esophagus. Luden's: Cough drop brand that includes a variety of flavors. Monistat: Provides fast relief for yeast infections and is available in several different doses. Nix: Effective and safe lice and super lice treatments. Summer's Eve: Offers a variety of feminine care products, including washes, cloths, and sprays. TheraTears: Doctor created and recommended brand for dry eye relief. International OTC Healthcare Fess: Helps relieve nasal and sinus congestion due to allergy, hay fever, colds and flu. Hydralyte: Relieves symptoms of dehydration and helps replace water and electrolytes lost due to vomiting, diarrhea, heavy sweating, vigorous exercise and occasional hangovers. Customers The company’s senior management team and dedicated sales force strive to maintain long-standing relationships with its top 25 U.S. customers. The company also contracts with third-party sales management enterprises that interface directly with many of its remaining customers and report directly to members of its sales management team. In an effort to ensure continued sales growth, the company continues to focus on expanding its reliance on direct sales while reducing its reliance on brokers. The company enjoys broad distribution across each of the major retail channels, including mass merchandisers, drug, food, dollar, convenience, club and e-commerce stores. During 2023, Walmart accounted for approximately 19.7% of the company’s gross revenues. Warehousing and Distribution The company manages product distribution in the continental United States through one facility, which is owned and operated by GEODIS Logistics LLC (GEODIS), a third-party provider since fiscal 2020. GEODIS provides warehouse services, including storage, handling and shipping, as well as transportation services, with respect to the company’s full line of products, including complete management services, carrier claims administration, proof of delivery, procurement, report generation, and freight payment services. Competition The company’s branded competitors include, among others, AbbVie Inc.; Alcon; Bausch + Lomb; Bayer AG; Combe; Haleon plc; Johnson & Johnson; Mondelez International; Reckitt Benckiser Group plc; Sanofi; Scholl's Wellness Company; Sunstar Group; The Honey Pot Company; and The Procter & Gamble Company. Regulation The formulation, manufacturing, packaging, labeling, distribution, importation, sale and storage of the company’s products are subject to extensive regulation by various U.S. federal agencies, including the U.S. Food and Drug Administration (FDA), the Federal Trade Commission (FTC), the Consumer Product Safety Commission (CPSC), and the Environmental Protection Agency (EPA), and various agencies of the states, localities and foreign countries in which its products are manufactured, marketed, distributed and sold. Most of the company’s U.S. OTC drug products are regulated pursuant to the FDA’s monograph system. Certain of the company’s U.S. OTC drug products are New Drug Application (NDA) or Abbreviated New Drug Application (ANDA) products and are manufactured and labeled in accordance with an FDA-approved submission. These products are subject to reporting requirements as set forth in FDA regulations. Certain of the company’s U.S. OTC Healthcare products are medical devices regulated by the FDA through a system that may involve pre-market clearance. Certain of the company’s products are considered cosmetics regulated by the FDA through the Federal Food, Drug, and Cosmetic Act (FDC Act); and the Fair Packaging and Labeling Act. In accordance with the FDC Act and FDA regulations, the company and its third-party manufacturers of the U.S. products must also comply with the FDA’s current Good Manufacturing Practices (GMPs). The company’s dietary supplement products are governed by the Dietary Supplement Health and Education Act of 1994 (DSHEA), which defines and regulates dietary supplements. Under DSHEA, supplements are also effectively regulated by the FDA for GMPs. A number of the company’s products are regulated by the CPSC under the Federal Hazardous Substances Act (FHSA), the Poison Prevention Packaging Act of 1970 (the PPPA) and the Consumer Products Safety Improvement Act of 2008 (CPSIA). In addition, a small number of the company’s products are subject to regulation under the PPPA and can only be legally marketed if they are dispensed in child-resistant packaging or labeled for use in households where there are no children. The CPSIA requires the company to make available to its customers certificates stating that the company is in compliance with any applicable regulation administered by the CPSC. The company’s EPA registered products are also subject to state regulations and the rules and regulations of the various jurisdictions where these products are sold. In addition, the company is subject to FTC and state regulations, as well as foreign regulations, relating to its product claims and advertising.i Intellectual Property Some of the most significant registered trademarks the company owns in the United States and/or Canada are BC, Boudreaux's Butt Paste, Chloraseptic, Clear Eyes, Compound W, Debrox, DenTek, Dramamine, Fleet, Gaviscon, Goody's, Hydralyte, Luden's, Monistat, Nix, Summer's Eve, Fess and TheraTears. History The company was founded in 1996 as a joint venture of Medtech Labs and The Shansby Group. It was incorporated in the state of Delaware in 2004. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare, Inc. in 2018.